July 13, 2017

Pivot Pharmaceuticals Files Application for Canadian Stock Exchange (CSE) Listing

March 30, 2017

Pivot Receives Notice of Allowance from USPTO

 
April 12, 2016

Pivot Pharmaceuticals Target Price : $2.10

March 29, 2016

Pivot pharma seeks financing to develop drugs for women’s cancer